Korsuva Injection, Solution
Product Images NDC 59353-065

4 FDA label images from Vifor (international), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Korsuva (NDC 59353-065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vifor (international), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Korsuva 01)

Chemical Structure (Korsuva 01)
Chemical structure diagram of difelikefalin, the active ingredient in Korsuva injection 50 mcg/mL, showing its molecular arrangement with annotated functional groups and side chains.*
FDA Label Image

Figure 1 (Korsuva 02)

Figure 1 (Korsuva 02)
A side-by-side line graph comparing the percentage of subjects over 12 weeks in two clinical trials of Korsuva (difelikefalin) injection versus placebo. Each graph shows increasing percentages of subjects reaching the endpoint, with Korsuva groups consistently higher than placebo in both trials.*
FDA Label Image

Principal Display Panel (1.3 mL Vial Label)

Principal Display Panel (1.3 mL Vial Label)
Korsuva 50 mcg/mL (65 mcg/1.3 mL) injection solution label for intravenous use. The label indicates a 1.3 mL single-dose vial, manufactured by Vifor (International) Inc. in Switzerland, with storage instructions at 20°C to 25°C (68°F to 77°F). It includes a barcode, lot and expiration date fields, and states to discard unused portions.*
FDA Label Image

Principal Display Panel (1.3 mL Tray Carton)

Principal Display Panel (1.3 mL Tray Carton)
Korsuva (difelikefalin) Injection 65 mcg/1.3 mL (50 mcg/mL) intravenous solution carton labeling. The packaging indicates a single-dose vial for intravenous use after hemodialysis, containing 12 vials of 1.3 mL each. Manufactured and marketed by Vifor (International), Inc. The label provides storage instructions and highlights the dose strength and composition details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.